Noxopharm Investor Briefing – 8 July
Noxopharm (ASX: NOX) Webcast Replay
Noxopharm (ASX: NXO) is an Australian-based, clinical stage drug development company which focuses on two areas of drug technology.
As a part of our ‘Meet the CEOs’ series, CEO Graham provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 8th July 2020 at 12pm (AEST).